More mess lies ahead!
22/09/23 -"Based on our recent discussion with the Carl Zeiss Meditec, it appears that earnings challenges are set to intensify in the near term due to – destocking of consumables, currency headwinds and the ..."
Pages
64
Language
English
Published on
22/09/23
You may also be interested by these reports :
20/05/25
The cut in our target price is attributable to the downgrading of our estimates, which now factor in a slower recovery than previously anticipated.
16/05/25
The 2024 EPS benefitted from some one-off tailwinds, in addition to the good cost control. Hence, while the EPS was significantly above estimates, it ...
16/05/25
Bastide’s Q3 revenue extended the positive trend, thanks to the continued strong growth in specialised activities and the recovery in the Homecare ...
16/05/25
We have removed Palantir, a software company with real-time, AI-driven decisions capabilities, from the peer group list due to its elevated ...